| Filed On | Filing |
|---|---|
| 28 Oct 2026 | 6-K |
| 22 Oct 2026 |
Form 3: Adler Oz, Director
No securities owned |
| 22 Oct 2026 |
Form 3: Zuloff-Shani Adi, Director
No securities owned |
| 06 Oct 2026 | SCHEDULE 13D/A |
| 06 Oct 2026 | 6-K |
| 30 Sep 2026 |
Form 4: Recanati Leon, Director
Granted 2,500 Stock Option (right to buy) |
| 30 Sep 2026 |
Form 4: Nimrodi Nir, Director
Granted 10,000 Stock Option (right to buy) |
| 30 Sep 2026 |
Form 4: Percy Adrian John, Director
Granted 2,500 Stock Option (right to buy) |
| 30 Sep 2026 |
Form 4: Falk Dan Michael, Director
Granted 2,500 Stock Option (right to buy) |
| 30 Sep 2026 | 6-K |
| 29 Sep 2026 | EFFECT |
| 28 Sep 2026 | 6-K |
| 28 Sep 2026 | POS AM |
| 15 Sep 2026 | 6-K |
| 11 Sep 2026 | SCHEDULE 13D/A |
| 11 Sep 2026 | SCHEDULE 13D/A |
| 04 Sep 2026 | 6-K |
| 28 Aug 2026 | SCHEDULE 13D/A |
| 27 Aug 2026 | 6-K |
| 26 Aug 2026 |
Form 4: Tarcic Gabi, Chief Development Officer
Bought 1,129 shares ($677) |
Loading...